Treatment Breakdown, 2013-2016

This website presents the numbers and percentages of tumours diagnosed in England in 2013 - 2016 recorded as receiving radiotherapy, chemotherapy or tumour resection. The results are presented by cancer site, year, stage at diagnosis, age, sex, deprivation, ethnicity, and comorbidities.

The methodology is described in the standard operating procedure CAS-SOP #4.5 Linking treatment tables - chemotherapy, tumour resections and radiotherapy.

Analytical notes:

Other care represents the group of patients who had no record of chemotherapy, tumour resection, or radiotherapy in the time frame assessed. This may include patients who received other treatments (such as hormonal therapy or management of symptoms), treatment outside of the time frame assessed, treatment in a private setting, or there may be data missing from the datasets used.

The patient's Charlson comorbidity score was derived from Hospital Episodes Statistics (HES) and Cancer Registry data combined, and looks back at the time period between 27 months to 3 months before the patient's cancer diagnosis.

Tumour resections have been defined for 23 sites.

These percentages have not been case-mix adjusted.

The breakdown by the factor of interest is not available on the overall tab.

When looking at independent treatments for 'All Malignant Neoplasms', note that 'other malignant neoplasms' are excluded from the surgery figures, but not the chemotherapy and radiotherapy figures. See the Information tab for more details.

Click below to download a copy of the data, and for TIFF outputs of the graphs:
Download Data for Overall Treatment Graph
Download Data for Independent Treatments Graph
Download Data for Treatment Combination Graphs
Download Raw Data for all Cancers
Export Overall Treatment Graph
Export Graph for Independent Treatments
Export Graph for Stacked Treatment Combination
Export Graph for Treatment Combination

This work has been produced as part of the Cancer Research UK - Public Health England Partnership.
This work uses data collected by the NHS, as part of the care and support of cancer patients.